Arcoma ABOSTO:ARCOMA -0.93%75 Days Inventory is 120.47 as of Mar. 2026, which is 10% above its 10-year median of 109.27. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.86 (Fairly Valued). The stock has 2 warning signs investors should review. Among 784 Medical Devices & Instruments companies, Arcoma AB ranks better than 70.54% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Arcoma AB's Average Total Inventories for the
three
months ended in Mar. 2026 was kr24.7 Mil. Arcoma AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr18.7 Mil.
Hence, Arcoma AB's Days Inventory for the
three
months ended in Mar. 2026 was 120.47.
The historical rank and industry rank for Arcoma AB's Days Inventory or its related term are showing as below:
OSTO:ARCOMA'
s Days Inventory Range Over the Past 10 Years
Min: 88 Med: 109.27 Max: 127.29
Current: 127.29
During the past 13 years, Arcoma AB's highest Days Inventory was 127.29. The lowest was 88.00. And the median was 109.27.
OSTO:ARCOMA's Days Inventory is ranked better than 70.54% of 784
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs OSTO:ARCOMA: 127.29
Arcoma AB's Days Inventory
declined
from Mar. 2025 (126.86) to Mar. 2026 (120.47).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Arcoma AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.76.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arcoma AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.79.
Arcoma AB (OSTO:ARCOMA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Arcoma AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arcoma AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Arcoma AB Days Inventory Related Terms
Arcoma AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Arcoma AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ARCOMA vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Arcoma AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcoma AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Arcoma AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcoma AB (OSTO:ARCOMA) has a Days Inventory of 120.47 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arcoma AB and its competitors. This is 10% above median its historical median of 109.27. Over the past decade, Arcoma AB's Days Inventory has ranged from 88.00 to 127.29. According to the industry distribution chart, Arcoma AB ranks #231 out of 784 companies in the Medical Devices & Instruments industry, placing it in the top 29.5%.
Is Arcoma AB's Days Inventory too high?
Arcoma AB's current Days Inventory of 120.47 is 10% above median its 10-year median of 109.27. Over the past 10 years, this metric has ranged from a low of 88.00 to a high of 127.29. The Medical Devices & Instruments industry median Days Inventory is 179.60. Arcoma AB's value of 120.47 is 32.9% below this industry median. Based on the distribution chart, Arcoma AB ranks #231 out of 784 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Arcoma AB ranks #231 out of 784 companies for Days Inventory. This puts Arcoma AB in the upper half of its industry. The industry median Days Inventory is 179.60. Arcoma AB's value of 120.47 is 32.9% below this benchmark. Historically, Arcoma AB's own Days Inventory has ranged from 88.00 to 127.29 over the past decade. While the company's 10-year median is 109.27 vs. the industry median of 179.60, Arcoma AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcoma AB's current Days Inventory of 120.47 is 32.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arcoma AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcoma AB's current Days Inventory is 120.47, which is 10% above median its own 10-year median of 109.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.86, compared to a current price of kr8.50 — trading 8.1% above its estimated fair value. The current Days Inventory is 120.47, which is 10% above median its 10-year median of 109.27 and 32.9% below the Medical Devices & Instruments industry median of 179.60. Arcoma AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Days Inventory is 120.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued.
The current stock price of kr8.50 is trading 8.1% above its estimated GF Value™ of kr7.86.
GuruFocus considers Arcoma AB to be Fairly Valued.
Key valuation signals for OSTO:ARCOMA:
Days Inventory: 120.47 (10% above median its 10-year median of 109.27)
GF Value™: kr7.86 vs. price of kr8.50 (8.1% above fair value)
Industry Position: 32.9% below the Medical Devices & Instruments median (#231 of 784)
No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score
Get the complete analysis for OSTO:ARCOMA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ARCOMA has been successfully added to your 
